2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz

56 views

August 15, 2018

Comments 0

The First Treatment Choice Matters

Feat. A. Ip

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Hodgkin Lymphoma

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

2018 Pan Pacific Lymphoma Conference

R. Hoppe

28 views

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

56 views

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

37 views

Use of Total Metabolic Tumor Volume in PET Scans

2018 Pan Pacific Lymphoma Conference

N. Hansen

137 views

Hodgkin Lymphoma: First Relapse Options

2018 Pan Pacific Lymphoma Conference

B. Pro

87 views

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

2018 Pan Pacific Lymphoma Conference

B. Pro

255 views

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

2018 Pan Pacific Lymphoma Conference

S. Ansell

40 views

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

2018 Pan Pacific Lymphoma Conference

A. Engert

29 views